These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16210117)

  • 1. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers.
    de Perrot M; Bonser RS; Dark J; Kelly RF; McGiffin D; Menza R; Pajaro O; Schueler S; Verleden GM;
    J Heart Lung Transplant; 2005 Oct; 24(10):1460-7. PubMed ID: 16210117
    [No Abstract]   [Full Text] [Related]  

  • 2. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes.
    Arcasoy SM; Fisher A; Hachem RR; Scavuzzo M; Ware LB;
    J Heart Lung Transplant; 2005 Oct; 24(10):1483-8. PubMed ID: 16210119
    [No Abstract]   [Full Text] [Related]  

  • 3. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: recipient-related risk factors and markers.
    Barr ML; Kawut SM; Whelan TP; Girgis R; Böttcher H; Sonett J; Vigneswaran W; Follette DM; Corris PA;
    J Heart Lung Transplant; 2005 Oct; 24(10):1468-82. PubMed ID: 16210118
    [No Abstract]   [Full Text] [Related]  

  • 4. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: introduction and methods.
    Christie JD; Van Raemdonck D; de Perrot M; Barr M; Keshavjee S; Arcasoy S; Orens J;
    J Heart Lung Transplant; 2005 Oct; 24(10):1451-3. PubMed ID: 16210115
    [No Abstract]   [Full Text] [Related]  

  • 5. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.
    Christie JD; Carby M; Bag R; Corris P; Hertz M; Weill D;
    J Heart Lung Transplant; 2005 Oct; 24(10):1454-9. PubMed ID: 16210116
    [No Abstract]   [Full Text] [Related]  

  • 6. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment.
    Shargall Y; Guenther G; Ahya VN; Ardehali A; Singhal A; Keshavjee S;
    J Heart Lung Transplant; 2005 Oct; 24(10):1489-500. PubMed ID: 16210120
    [No Abstract]   [Full Text] [Related]  

  • 7. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.
    Prekker ME; Nath DS; Walker AR; Johnson AC; Hertz MI; Herrington CS; Radosevich DM; Dahlberg PS
    J Heart Lung Transplant; 2006 Apr; 25(4):371-8. PubMed ID: 16563963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for primary graft dysfunction after lung transplantation.
    Whitson BA; Nath DS; Johnson AC; Walker AR; Prekker ME; Radosevich DM; Herrington CS; Dahlberg PS
    J Thorac Cardiovasc Surg; 2006 Jan; 131(1):73-80. PubMed ID: 16399297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation.
    Bittner HB; Richter M; Kuntze T; Rahmel A; Dahlberg P; Hertz M; Mohr FW
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):210-5. PubMed ID: 16386921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation injury and donor selection: it all starts here.
    Strasberg SM
    Liver Transpl Surg; 1997 Sep; 3(5 Suppl 1):S1-7. PubMed ID: 9377764
    [No Abstract]   [Full Text] [Related]  

  • 11. Ischemia-reperfusion-induced lung injury.
    de Perrot M; Liu M; Waddell TK; Keshavjee S
    Am J Respir Crit Care Med; 2003 Feb; 167(4):490-511. PubMed ID: 12588712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recipient treatment with L-arginine attenuates donor lung injury associated with hemorrhagic shock.
    Preissler G; Löhe F; Ebersberger U; Huff I; Bittmann I; Messmer K; Jauch KW; Angele MK
    Transplantation; 2009 Jun; 87(11):1602-8. PubMed ID: 19502950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current strategies in lung preservation.
    Kelly RF
    J Lab Clin Med; 2000 Dec; 136(6):427-40. PubMed ID: 11128744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary lung transplantation: the UCLA experience.
    Sherman W; Rabkin D; Ross D; Ardehali A;
    Clin Transpl; 2008; ():163-70. PubMed ID: 19708455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of aerodynamic changes for assessing pulmonary injury in the isolated perfused working lung model.
    LoCicero J; Massad M; Khasho FH; Matano J; Greene R; deTarnowsky J
    Transplant Proc; 1990 Apr; 22(2):559-60. PubMed ID: 2326983
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of donor lung injury in heart-beating versus non-heart-beating donors.
    Neyrinck AP; Van De Wauwer C; Geudens N; Rega FR; Verleden GM; Wouters P; Lerut TE; Van Raemdonck DE
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):628-36. PubMed ID: 16942886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures.
    Thabut G; Castier Y; Mal H
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1408; author reply 1408-9. PubMed ID: 18544413
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential pulmonary vein gases predict primary graft dysfunction.
    Botha P; Trivedi D; Searl CP; Corris PA; Schueler SV; Dark JH
    Ann Thorac Surg; 2006 Dec; 82(6):1998-2002. PubMed ID: 17126097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The possibilities of biological preservation of a multiple organ donor].
    Barinov EF
    Grudn Khir; 1988; (5):38-44. PubMed ID: 3061880
    [No Abstract]   [Full Text] [Related]  

  • 20. Donor fat embolism and primary graft dysfunction after lung transplantation.
    Padilla J; Jordá C; Peñalver JC; Cerón J; Escrivá J; Vera-Sempere F
    Ann Thorac Surg; 2007 Aug; 84(2):e4-5. PubMed ID: 17643598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.